Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults

Ge Li, Jane B. Shofer, Eric C. Petrie, Chang En Yu, Charles W. Wilkinson, Dianne P. Figlewicz, Andrew Shutes-David, Jing Zhang, Thomas J. Montine, Murray A. Raskind, Joseph Quinn, Douglas R. Galasko, Elaine R. Peskind

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. Methods: CSF amyloid beta1-42 (Aβ42), phospho-Tau-181 (p-Tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF E-selectin and vascular cell adhesion protein 1 (VCAM1) were measured in 249 participants who were between the ages of 50 and 100. Results: CSF total tau and p-Tau181 increased with age over the adult life span (p < 0.01) with no gender differences in those increases. CSF Aβ42 concentration varied according to age, gender, and APOE genotype (interaction of age × gender × ϵ4, p = 0.047). CSF VCAM1, but not E-selectin, increased with age (p < 0.01), but both were elevated in men compared to women (p < 0.01). Conclusions: Female APOE-ϵ4 carriers appear at higher risk for AD after age 50. In contrast, men may experience a relatively higher rate of cerebrovascular injury in middle and early old age.

Original languageEnglish (US)
Article number48
JournalAlzheimer's Research and Therapy
Volume9
Issue number1
DOIs
StatePublished - Jul 3 2017

Fingerprint

Vascular Diseases
Cerebrospinal Fluid
Alzheimer Disease
Biomarkers
Genotype
E-Selectin
Amyloid
Wounds and Injuries
Cell Adhesion
Blood Vessels
Proteins

Keywords

  • Age
  • Alzheimer's disease
  • APOE genotype
  • Biomarkers
  • Cerebrospinal fluid
  • Cerebrovascular disease
  • Gender

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cognitive Neuroscience

Cite this

Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. / Li, Ge; Shofer, Jane B.; Petrie, Eric C.; Yu, Chang En; Wilkinson, Charles W.; Figlewicz, Dianne P.; Shutes-David, Andrew; Zhang, Jing; Montine, Thomas J.; Raskind, Murray A.; Quinn, Joseph; Galasko, Douglas R.; Peskind, Elaine R.

In: Alzheimer's Research and Therapy, Vol. 9, No. 1, 48, 03.07.2017.

Research output: Contribution to journalArticle

Li, G, Shofer, JB, Petrie, EC, Yu, CE, Wilkinson, CW, Figlewicz, DP, Shutes-David, A, Zhang, J, Montine, TJ, Raskind, MA, Quinn, J, Galasko, DR & Peskind, ER 2017, 'Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults', Alzheimer's Research and Therapy, vol. 9, no. 1, 48. https://doi.org/10.1186/s13195-017-0271-9
Li, Ge ; Shofer, Jane B. ; Petrie, Eric C. ; Yu, Chang En ; Wilkinson, Charles W. ; Figlewicz, Dianne P. ; Shutes-David, Andrew ; Zhang, Jing ; Montine, Thomas J. ; Raskind, Murray A. ; Quinn, Joseph ; Galasko, Douglas R. ; Peskind, Elaine R. / Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. In: Alzheimer's Research and Therapy. 2017 ; Vol. 9, No. 1.
@article{1905af086a2f41a6a08e378472ca3191,
title = "Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults",
abstract = "Background: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. Methods: CSF amyloid beta1-42 (Aβ42), phospho-Tau-181 (p-Tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF E-selectin and vascular cell adhesion protein 1 (VCAM1) were measured in 249 participants who were between the ages of 50 and 100. Results: CSF total tau and p-Tau181 increased with age over the adult life span (p < 0.01) with no gender differences in those increases. CSF Aβ42 concentration varied according to age, gender, and APOE genotype (interaction of age × gender × ϵ4, p = 0.047). CSF VCAM1, but not E-selectin, increased with age (p < 0.01), but both were elevated in men compared to women (p < 0.01). Conclusions: Female APOE-ϵ4 carriers appear at higher risk for AD after age 50. In contrast, men may experience a relatively higher rate of cerebrovascular injury in middle and early old age.",
keywords = "Age, Alzheimer's disease, APOE genotype, Biomarkers, Cerebrospinal fluid, Cerebrovascular disease, Gender",
author = "Ge Li and Shofer, {Jane B.} and Petrie, {Eric C.} and Yu, {Chang En} and Wilkinson, {Charles W.} and Figlewicz, {Dianne P.} and Andrew Shutes-David and Jing Zhang and Montine, {Thomas J.} and Raskind, {Murray A.} and Joseph Quinn and Galasko, {Douglas R.} and Peskind, {Elaine R.}",
year = "2017",
month = "7",
day = "3",
doi = "10.1186/s13195-017-0271-9",
language = "English (US)",
volume = "9",
journal = "Alzheimer's Research and Therapy",
issn = "1758-9193",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults

AU - Li, Ge

AU - Shofer, Jane B.

AU - Petrie, Eric C.

AU - Yu, Chang En

AU - Wilkinson, Charles W.

AU - Figlewicz, Dianne P.

AU - Shutes-David, Andrew

AU - Zhang, Jing

AU - Montine, Thomas J.

AU - Raskind, Murray A.

AU - Quinn, Joseph

AU - Galasko, Douglas R.

AU - Peskind, Elaine R.

PY - 2017/7/3

Y1 - 2017/7/3

N2 - Background: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. Methods: CSF amyloid beta1-42 (Aβ42), phospho-Tau-181 (p-Tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF E-selectin and vascular cell adhesion protein 1 (VCAM1) were measured in 249 participants who were between the ages of 50 and 100. Results: CSF total tau and p-Tau181 increased with age over the adult life span (p < 0.01) with no gender differences in those increases. CSF Aβ42 concentration varied according to age, gender, and APOE genotype (interaction of age × gender × ϵ4, p = 0.047). CSF VCAM1, but not E-selectin, increased with age (p < 0.01), but both were elevated in men compared to women (p < 0.01). Conclusions: Female APOE-ϵ4 carriers appear at higher risk for AD after age 50. In contrast, men may experience a relatively higher rate of cerebrovascular injury in middle and early old age.

AB - Background: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. Methods: CSF amyloid beta1-42 (Aβ42), phospho-Tau-181 (p-Tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF E-selectin and vascular cell adhesion protein 1 (VCAM1) were measured in 249 participants who were between the ages of 50 and 100. Results: CSF total tau and p-Tau181 increased with age over the adult life span (p < 0.01) with no gender differences in those increases. CSF Aβ42 concentration varied according to age, gender, and APOE genotype (interaction of age × gender × ϵ4, p = 0.047). CSF VCAM1, but not E-selectin, increased with age (p < 0.01), but both were elevated in men compared to women (p < 0.01). Conclusions: Female APOE-ϵ4 carriers appear at higher risk for AD after age 50. In contrast, men may experience a relatively higher rate of cerebrovascular injury in middle and early old age.

KW - Age

KW - Alzheimer's disease

KW - APOE genotype

KW - Biomarkers

KW - Cerebrospinal fluid

KW - Cerebrovascular disease

KW - Gender

UR - http://www.scopus.com/inward/record.url?scp=85021628789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021628789&partnerID=8YFLogxK

U2 - 10.1186/s13195-017-0271-9

DO - 10.1186/s13195-017-0271-9

M3 - Article

C2 - 28673336

AN - SCOPUS:85021628789

VL - 9

JO - Alzheimer's Research and Therapy

JF - Alzheimer's Research and Therapy

SN - 1758-9193

IS - 1

M1 - 48

ER -